Skip to content
ppharmaranks
Menu

AZULFIDINE EN-TABS vs SFROWASA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 18, 2026·How we rate

Possible drug interaction. AZULFIDINE EN-TABS and SFROWASA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Rating

64/100
New

Pharmacy pays

~$5.92 /30
~$26.72 /30

Type

RX
RX

Active ingredient

SULFASALAZINE
MESALAMINE

Dosage forms

Tablet, delayed release
Enema, Suspension

Drug class

Aminosalicylate
Aminosalicylate

Boxed warning

None
None

Half-life

about 7 to 9 hours (apparent terminal half-life)

Treats

Juvenile Arthritis, Rheumatoid Arthritis, Ulcerative Colitis
Ulcerative Colitis, Proctitis, Sigmoid Diseases

Frequently asked questions

Which is cheaper, Azulfidine En-Tabs or Sfrowasa?

Azulfidine En-Tabs costs pharmacies less to acquire — about $5.92 vs $26.72 for a 30-count supply, per the CMS NADAC survey. That gap is in the pharmacy's cost of goods, not necessarily in what you pay: your price is set afterwards by your insurer and the pharmacy.

What is the difference between Azulfidine En-Tabs and Sfrowasa?

Azulfidine En-Tabs contains Sulfasalazine, while Sfrowasa contains Mesalamine — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.